Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

by Iago Dillion Lima Cavalcanti
Save 35% Save 35%
Current price ₹5,509.00
Original price ₹8,474.00
Original price ₹8,474.00
Original price ₹8,474.00
(-35%)
₹5,509.00
Current price ₹5,509.00

Imported Edition - Ships in 12-14 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9783030683337
  • Binding: Paperback
  • Subject: N/A
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Publication Date:
  • Pages: 109
  • Original Price: EUR 74.99
  • Language: English
  • Edition: 2021
  • Item Weight: 227 grams
  • BISAC Subject(s): Oncology / General, Internal Medicine, and Pharmacy

From the Back Cover
This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment.

We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells.

The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment.

This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.

Iago Dillion Lima Cavalcanti

Pharmacist, Specialist in Cancer Care and Palliative Care at the Centro Universitário Tabosa de Almeida. He obtained a Master's degree in Pharmaceutical Sciences from the Universidade Federal de Pernambuco.

José Cleberson Santos Soares

Pharmacist, Specialist in Oncology Pharmacy at the Centro de Capacitação Educacional. He obtained a Master's degree in Pharmaceutical Sciences from the Universidade Federal de Pernambuco.


Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us